JAMDA
December 28, 2021
Showing 31 - 40 of 58 results
JAMDA
December 14, 2021
As-Needed Prescribing and Administration of Psychotropic Medications in Assisted Living: A 7-State Study
Psychotropic medications administered on an as-needed basis, often designated as pro re nata (or PRN, hereafter as-needed), can alleviate acute symptoms and facilitate deprescribing, although as-needed use is associated with negative outcomes such as polypharmacy and drug interactions. The aim of this stud...
JAMDA
November 8, 2021
Melatonin Prescribing in Assisted Living
Aging is associated with sleep problems, which are common among assisted living (AL) residents. More than 40% of residents have insomnia, and almost 70% have a sleep disturbance of some kind. Melatonin to treat sleep disorders has become common among older adults, but its use in AL is unknown, which is con...
JAMDA
July 19, 2021
The Association of Service Use and Other Client Factors with the Time to Transition from Home Care to Facility-Based Care
People are living longer with complex health needs and wish to remain in their homes as their care needs change. We examined which client factors (sociodemographic, health service use, health, and function) influenced older persons’ (≥65 years) time to transition from home living to assisted living (AL) or...
JAMDA
June 12, 2021
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
COVID-19 disproportionately impacts residents in long-term care facilities. Our objective was to quantify the presence and magnitude of antibody response in vaccinated, older adult residents at assisted living, personal care, and independent living communities.
JAMDA
February 24, 2021
COVID-19 Recommendations for Assisted Living: Implications for the Future
Assisted living (AL) emerged over 2 decades ago as a preferred residential care option for older adults who require supportive care; however, as resident acuity increased, concern has been expressed whether AL sufficiently addresses health care needs. COVID-19 amplified those concerns, and an examination o...
JAMDA
January 28, 2021
Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon
Explore community- and resident-level characteristics associated with polypharmacy and use of cognition-enhancing, antipsychotic, and opioid medications among a statewide representative sample of assisted living and residential care (AL/RC) residents.
JAMDA
December 28, 2020
To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living?
In nursing homes (NHs), psychoactive medication use has received notable attention, but less is known about prescribing in assisted living (AL). This study examined how antipsychotic and antianxiety medication prescribing in AL compares with NHs.
JAMDA
November 12, 2020
Variability and Potential Determinants of Assisted Living State Regulatory Stringency
We examined state variations in assisted living (AL) regulatory policies for admission/retention, staffing/training, medication management, and dementia care. Factors associated with domain-specific and overall regulatory stringency were identified.
JAMDA
October 31, 2020
Testing the Implementation of Function-focused Care in Assisted Living Settings
The purpose of this study was to evaluate the Function-Focused Care for Assisted Living Using the Evidence Integration Triangle (FFC-AL-EIT) intervention.
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.
